Weimi Bio-Tech
Guangzhou
About Weimi Bio-Tech
Weimi Bio-Tech develops immunofluorescence chromatography products used in inflammation detection, prenatal testing, cervical cancer diagnosis, and cardio-cerebral-vascular testing. They provide comprehensive product solutions and services for medical laboratories.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $16.4M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2022)
- Website: weimibio.com
- Phone: +86 020-8235-0856
Industries & Categories
Health Care, Medical
Canonical: https://fsome.com/organization/weimi-bio-tech-108 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.